A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia
Shah, Bijal D., Rozario, Nicole, Turba, Elyce P., Bello, Celeste, Chavez, Julio C., Sokol, Lubomir, Brayer, Jason, Lancet, Jeffrey E.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function
Chavez, Julio C., Grajales-Cruz, Ariel F, Volpe, Virginia Olivia, Turba, Elyce P., Nodzon, Lisa, Sahakian, Eva, Rozario, Nicole, Pinilla Ibarz, Javier
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody
Grajales-Cruz, Ariel F, Chavez, Julio, Volpe, Virginia Olivia, Sandoval-Sus, Jose, Shah, Bijal, Bello, Celeste, Sokol, Lubomir, Fisher, Shanel, Nair, Rajesh R, Seongseok, Yun, Saeed, Hayder, Isenalumhe, Leidy, Turba, Elyce P., Nodzon, Lisa, Pinilla Ibarz, Javier
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia
Grajales-Cruz, Ariel Felipe, Chavez, Julio C., Turba, Elyce P., Nodzon, Lisa, Perez Leal, Francisco, Sandoval-Sus, Jose, Komrokji, Rami S., Locke, Frederick L., Kharfan-Dabaja, Mohamed A, Shah, Bijal D., Sokol, Lubomir, Bello, Celeste M., Pinilla Ibarz, Javier
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article